Y-Intercept (HK)’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-141,675
Closed -$12.1M 1766
2026
Q1
$12.1M Buy
+141,675
New +$12.6M 0.23% 83
2025
Q4
Sell
-167,905
Closed -$13.4M 1600
2025
Q3
$13.4M Buy
167,905
+101,472
+153% +$8.66M 0.32% 43
2025
Q2
$6.04M Buy
66,433
+64,042
+2,678% +$5.85M 0.15% 165
2025
Q1
$224K Sell
2,391
-37,250
-94% -$3.34M 0.02% 1014
2024
Q4
$3.6M Buy
39,641
+13,698
+53% +$1.31M 0.24% 96
2024
Q3
$2.69M Buy
+25,943
New +$2.64M 0.16% 141
2024
Q2
Sell
-4,715
Closed -$425K 1456
2024
Q1
$425K Buy
+4,715
New +$399K 0.03% 798
2023
Q4
Sell
-24,740
Closed -$1.76M 1274
2023
Q3
$1.76M Sell
24,740
-5,810
-19% -$434K 0.17% 170
2023
Q2
$2.35M Buy
+30,550
New +$2.36M 0.25% 86
2023
Q1
Sell
-17,612
Closed -$1.39M 1219
2022
Q4
$1.39M Sell
17,612
-42,061
-70% -$3.15M 0.2% 118
2022
Q3
$4.19M Buy
+59,673
New +$4.68M 0.42% 28
2021
Q3
Sell
-18,815
Closed -$1.53M 675
2021
Q2
$1.53M Buy
+18,815
New +$1.54M 0.39% 40
2021
Q1
Sell
-8,891
Closed -$753K 640
2020
Q4
$753K Buy
+8,891
New +$735K 0.32% 75

Other funds holding CL

Y-Intercept (HK)'s CL Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 141,675 shares — an estimated $12.1M sold.

Y-Intercept (HK) first reported a position in CL in Q4 2020 and held it in 13 quarters. The position peaked at $13.4M in Q3 2025. 470 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Y-Intercept (HK) reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 141,675 Colgate-Palmolive shares in Q2 2026, an estimated $12.1M.
  • Y-Intercept (HK) first reported a position in Colgate-Palmolive in Q4 2020 and held it in 13 quarters.
  • Y-Intercept (HK)'s Colgate-Palmolive position peaked at $13.4M in Q3 2025.
  • 470 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.